Hepatic insulin resistance in antipsychotic naive schizophrenic patients: Stable isotope studies of glucose metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 2, 2008, Pages 572-577

  Van Nimwegen, Lonneke J M ^a   Storosum, Jitschak G ^a,b   Blumer, Regje M E ^a   Allick, Gideon ^a   Venema, Henk W ^a   De Haan, Lieuwe ^a   Becker, Hiske ^a   Van Amelsvoort, Therese ^a   Ackermans, Mariette T ^a   Fliers, Eric ^a   Serlie, Mireille J M ^a   Sauerwein, Hans P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; NEUROLEPTIC AGENT;

ABDOMINAL FAT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT CONTENT; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISOTOPE LABELING; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 39049127051     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1167     Document Type: Article

References (40)

1. Kohen D 2004 Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry Suppl 47:S64-S66
2. Holt RI, Bushe C, Citrome L 2005 Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol 19(Suppl 6):56-65
3. Citrome L, Jaffe A, Levine J, Allingham B, Robinson J 2004 Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatr Serv 55:1006-1013
4. Leslie DL, Rosenheck RA 2004 Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 161:1709-1711
5. Ryan MC, Collins P, Thakore JH 2003 Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160:284-289
6. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R 2002 Increased visceral fat distribution in drug naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26:137-141
7. Ryan MC, Flanagan S, Kinsella U, Keeling F, Thakore JH 2004 The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci [Erratum (2004) 75:2851] 74:1999-2008
8. Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, Navarro MA, San L 2004 Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry 65:1335-1342
9. Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP 2004 Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 184:58-62
10. Cohn TA, Remington G, Zipursky RB, Azad A, Connolly P, Wolever TM 2006 Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report. Can J Psychiatry 5:382-386
11. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
12. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD 2004 Lipolysis in human obesity. J Clin Invest 113:1582-1588
13. Koutsari C, Jensen MD 2006 Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 47:1643-1650
14. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS 2006 Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29:2457-2461
15. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
16. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bhain BE, Lodish HF 2001 Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010
17. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
18. 13C]glycerol. J Clin Endocrinol Metab 86:2220-2226
19. de Bos Kuil MJ, Endert E, Fliers E, Prummel MF, Romijn JA, Wiersinga WM 1998 Establishment of reference values for endocrine tests. I: Cushing's syndrome. Neth J Med 53:153-163
20. Frayn KN 1983 Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628-634
21. Dixon AK 1983 Abdominal fat assessed by computed tomography: sex difference in distribution. Clin Radiol 34:189-191
22. Weits T, van der Beek EJ, Wedel M, Ter Haar Romeny BM 1988 Computer tomography measurement of abdominal fat deposition in relation to anthropometry. Int J Obes 12:217-225
23. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J 1998 Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871-875
24. Potretzke AM, Schmitz KH, Jensen MD 2004 Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res 12:1698-1701
25. Finegood DT, Bergman RN, Vranic M 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924
26. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C, Tatranni PA 2003 Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 26:3315-3319
27. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552-2563
28. Boden G, Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32:14-23
29. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA 2005 Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54:3148-3152
30. Misra A, Vikram NK 2003 Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19:457-466
31. Kapoor D, Jones TH 2005 Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152:491-499
32. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS 2004 Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 17:350:2549-2557
33. Cnop M, Landschild MJ, Vidal J, Havel J, Knowles NG, Carr DR, Wang F, Hull F, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE 2002 The concurrent accumulation of intra abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005-1015
34. Demuro G, Obici S 2006 Central nervous system and control of endogenous glucose production. Curr Diab Rep 6:188-193
35. Obici S, Zhang BB, Karkanias G, Rossetti L 2002 Hypothalamic insulin signalling is required for inhibition of glucose production. Nat Med 12:1376-1382
36. Connolly CC, Myers SR, Neal DW, Hastings JR, Cherrington AD 1996 In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes 45:1805-1813
37. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rosetti L 2005 Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026-1031
38. Kreier F, Fliers E, Voshol PJ, van Eden C, Havekes LM, Kalsbeek A, van Heijningen CL, Sluiter AA, Mettenleier TC, Romijn J, Sauerwein HP, Buijs RM 2002 Selective parasympathetic innervation of subcutaneous and intra-abdominal fat - functional implications. J Clin Invest 110:1243-1250
39. Kreier F, Kap YS, Mettenleier TC, van Heijningen C, van der Vliet J, Kalsbeek A, Sauerwein HP, Fliers E, Romijn J, Buijs RM 2006 Tracing from fat tissue, liver and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 147:1140-1147
40. Tkachev D, Mimmack ML, Huffaker SJ, Ryan M, Bahn S 2007 Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int J Neuropsychopharmacol 12:1-7